Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab for acute renal allograft rejection in pediatrics
NCT00697996Phase 3Completed
- Sponsor
- Stanford University
- Start
- Jun 2005
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in kidney transplant rejection, sponsored by Stanford University. Started Jun 2005; status: completed.
02
Drugs
rituximab
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00697996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00697996.